Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral
Royal College of Physicians, 2006 - Chronic renal failure - 101 pages
These guidelines provide a comprehensive guide to diagnosis and management of patients with chronic kidney disease.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Prediction of GFR from age and serum creatinine
ACEIs and ARBs albumin excretion amongst patients anaemia antihypertensive ARAS assessment atherosclerotic biopsy blood pressure cardiovascular disease cardiovascular risk chronic kidney disease chronic renal failure CKD stage Clin clinical coronary creatinine clearance cystatin detection diabetes mellitus diabetic nephropathy dialysis drugs end-stage renal epoetin estimated GFR estimation of GFR evidence g/dL glomerular filtration rate guidelines haematuria haemoglobin heart failure hyperkalaemia hypertension intervention K/DOQI kidney biopsy kidney damage kidney function Kidney Int laboratory Late referral left ventricular lipid-lowering Management and referral marker measurement of serum mg/mmol microalbuminuria microscopic haematuria mortality Nephrol Dial Transplant nephrologist NSAIDs outcomes patients with CKD patients with diabetes phosphate population progressive kidney protein excretion proteinuria recommendations reduced renal artery stenosis Renal Association renal disease renal function renal insufficiency risk factors serum creatinine concentration Soc Nephrol specialist stage 3 CKD target therapy treatment type 2 diabetes urinalysis Urol urological vascular disease
Page 95 - The Diabetes Control and Complications Trial Research Group. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.
Page 93 - Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus ; results of the HOPE study and MICRO-HOPE substudy. Lancet, 355 : 253-9, 2000.
Page 94 - Disease and the Council for High Blood Pressure Research of the American Heart Association.
Page 93 - Effects of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000 342, 145-53.
Page 93 - Brenner BM, Cooper ME, De Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861-9.